Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 300
Summary
- Conditions
- Lung Diseases
- Lung Neoplasms
- Smoking Reduction
- Tobacco Smoking
- Tobacco Use
- Tomography
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 55 years and 80 years
- Gender
- Both males and females
Description
This trial is a pragmatic randomized trial targeting the care of current smokers who are participating in lung cancer screening at two VA sites. Primary care providers at these sites will be randomized, and half will be offered tools to help integrate proactive smoking cessation support into the lun...
This trial is a pragmatic randomized trial targeting the care of current smokers who are participating in lung cancer screening at two VA sites. Primary care providers at these sites will be randomized, and half will be offered tools to help integrate proactive smoking cessation support into the lung cancer screening process. Key proactive elements include proactive telephone outreach to all current smokers by a VA Quitline counselor that follows mailed results letters, and providing providers guidance in offering proactive cessation medication support as part of the lung cancer screening process.
Tracking Information
- NCT #
- NCT03612804
- Collaborators
- Fred Hutchinson Cancer Research Center
- Investigators
- Principal Investigator: Steven B. Zeliadt, PhD MPH VA Puget Sound Health Care System Seattle Division, Seattle, WA
Get Well Soon